Antiviral Research
Academic journal
 | |
| Discipline | Antiviral drugs |
|---|---|
| Language | English |
| Edited by | Subhash Vasudevan |
| Publication details | |
| History | 1981–present |
| Publisher | Elsevier |
| Frequency | Monthly |
Impact factor | 7.6 (2022) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Antivir. Res. |
| NLM | Antiviral Res |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 0166-3542 |
| OCLC no. | 610588089 |
| Links | |
| |
Antiviral Research is a monthly peer-reviewed medical journal published by Elsevier covering research on all aspects of the development of drugs, vaccines and immunotherapies against viruses of animals and plants. The journal was established in 1981 and is an official publication of the International Society for Antiviral Research. The editor-in-chief is Subhash Vasudevan.[1]
Abstracting and indexing
Antiviral Research is abstracted and indexed in Abstracts on Hygiene and Communicable Diseases, Elsevier BIOBASE, BIOSIS, Current Contents/Life Sciences, EMBASE, MEDLINE, PASCAL, FRANCIS, Science Citation Index, Scopus, and Tropical Diseases Bulletin. According to the Journal Citation Reports, the journal has a 2022 impact factor of 7.6.[2]
References
- ^ "Editorial board - Antiviral Research | ScienceDirect.com by Elsevier". www.sciencedirect.com.
- ^ "Antiviral Research". 2022 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2022.
External links
- Official website
- v
- t
- e
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
- v
- t
- e
